Morgan Stanley Silence Therapeutics PLC Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Morgan Stanley holds 721,417 shares of SLN stock, worth $4.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

721,417

Previous 303,993 137.31%

Holding current value

$4.57 Million

Previous $5.78 Million 127.22%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.53 - $21.74 $6.48 Million - $9.07 Million	417,424 Added 137.31%	721,417 $13.1 Million
Q2 2024 Oct 17, 2024	BUY	$18.31 - $23.91 $1.12 Million - $1.46 Million	61,223 Added 25.22%	303,993 $5.78 Million
Q2 2024 Aug 14, 2024	BUY	$18.31 - $23.91 $1.12 Million - $1.46 Million	61,223 Added 25.22%	303,993 $5.78 Million
Q1 2024 Oct 17, 2024	SELL	$17.39 - $26.25 $1.06 Million - $1.61 Million	-61,223 Reduced 20.14%	242,770 $5.24 Million
Q1 2024 Aug 16, 2024	BUY	$17.39 - $26.25 $3.13 Million - $4.72 Million	179,962 Added 286.53%	242,770 $5.24 Million
Q1 2024 May 15, 2024	BUY	$17.39 - $26.25 $3.13 Million - $4.72 Million	179,962 Added 286.53%	242,770 $5.24 Million
Q4 2023 Aug 16, 2024	SELL	$6.7 - $17.67 $1.62 Million - $4.26 Million	-241,185 Reduced 79.34%	62,808 $1.09 Million
Q4 2023 Feb 13, 2024	BUY	$6.7 - $17.67 $63,723 - $168,059	9,511 Added 17.85%	62,808 $1.09 Million
Q3 2023 Nov 15, 2023	SELL	$5.07 - $10.74 $62,406 - $132,198	-12,309 Reduced 18.76%	53,297 $523,000
Q2 2023 Aug 14, 2023	SELL	$4.61 - $7.44 $32,597 - $52,608	-7,071 Reduced 9.73%	65,606 $360,000
Q1 2023 May 15, 2023	SELL	$6.2 - $15.61 $857,435 - $2.16 Million	-138,296 Reduced 65.55%	72,677 $450,000
Q4 2022 Feb 14, 2023	BUY	$9.69 - $17.09 $540,837 - $953,861	55,814 Added 35.97%	210,973 $3.22 Million
Q3 2022 Nov 14, 2022	BUY	$2.65 - $29.85 $4,944 - $55,700	1,866 Added 1.22%	155,159 $1.56 Million
Q2 2022 Oct 27, 2022	BUY	$7.99 - $19.5 $12,999 - $31,726	1,627 Added 1.07%	153,293 $1.82 Million
Q2 2022 Aug 15, 2022	BUY	$7.99 - $19.5 $12,999 - $31,726	1,627 Added 1.07%	153,293 $1.82 Million
Q1 2022 Oct 27, 2022	SELL	$16.5 - $23.89 $26,845 - $38,869	-1,627 Reduced 1.06%	151,666 $2.88 Million
Q1 2022 May 13, 2022	SELL	$16.5 - $23.89 $250,602 - $362,841	-15,188 Reduced 9.1%	151,666 $2.88 Million
Q4 2021 Feb 14, 2022	BUY	$20.61 - $25.71 $3.22 Million - $4.02 Million	156,239 Added 1471.87%	166,854 $3.99 Million
Q3 2021 Nov 15, 2021	BUY	$20.61 - $26.87 $218,775 - $285,225	10,615 New	10,615 $218,000

Others Institutions Holding SLN

# of Institutions

Shares Held

28.1M

Call Options Held

300

Put Options Held

View Full List

About Silence Therapeutics plc

Ticker SLN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,888,400
Market Cap $227M
Description
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...

More about SLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account